Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.
about
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 TrialCurrent concepts and controversies in the management of early stage Hodgkin lymphoma.Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease.
P2860
Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Stage I-IIA non-bulky Hodgkin' ...... eful? The Stanford experience.
@ast
Stage I-IIA non-bulky Hodgkin' ...... eful? The Stanford experience.
@en
Stage I-IIA non-bulky Hodgkin' ...... eful? The Stanford experience.
@nl
type
label
Stage I-IIA non-bulky Hodgkin' ...... eful? The Stanford experience.
@ast
Stage I-IIA non-bulky Hodgkin' ...... eful? The Stanford experience.
@en
Stage I-IIA non-bulky Hodgkin' ...... eful? The Stanford experience.
@nl
prefLabel
Stage I-IIA non-bulky Hodgkin' ...... eful? The Stanford experience.
@ast
Stage I-IIA non-bulky Hodgkin' ...... eful? The Stanford experience.
@en
Stage I-IIA non-bulky Hodgkin' ...... eful? The Stanford experience.
@nl
P2093
P2860
P1476
Stage I-IIA non-bulky Hodgkin' ...... eful? The Stanford experience.
@en
P2093
David M Baer
Joseph Mason
Lauren S Maeda
Ranjana H Advani
Richard T Hoppe
Sandra J Horning
Saul A Rosenberg
P2860
P304
P356
10.1016/J.IJROBP.2010.07.041
P407
P577
2010-10-08T00:00:00Z